You just read:

Impax Pharmaceuticals Resubmits New Drug Application for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066)

News provided by

Impax Laboratories, Inc.

Apr 11, 2014, 07:15 ET